SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-000026
Filing Date
2017-01-03
Accepted
2017-01-03 16:27:04
Documents
3
Period of Report
2017-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K-STEIN kura-8k_20170103.htm 8-K 34160
2 EX-99.1 kura-ex991_23.htm EX-99.1 11897
3 GRAPHIC g201701031701232964617.jpg GRAPHIC 4417
  Complete submission text file 0001564590-17-000026.txt   53629
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 17502117
SIC: 2834 Pharmaceutical Preparations